Finance

Beta
Lists
LEGN:NASDAQ
Legend Biotech Corp
$33.80
+32.50%
(+8.29) 1D
Jun 2, 12:24:56 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LEGN...
Open
$25.37
High
$35.38
Low
$25.25
Mkt. cap
6.30B
Avg. vol.
2.57M
Volume
8.87M
52-wk high
$45.30
52-wk low
$16.25
EPS
-$1.36
Beta
0.35
Shares outstanding
184.96M
No. of employees
3K
Open
$25.37
High
$35.38
Low
$25.25
Mkt. cap
6.30B
Avg. vol.
2.57M
Volume
8.87M
52-wk high
$45.30
52-wk low
$16.25
EPS
-$1.36
Beta
0.35
Shares outstanding
184.96M
No. of employees
3K
News stories
From sources across the web
About Legend Biotech Corp
CEO-
Employees3.1K
FoundedNov 17, 2014
HeadquartersSomerset, New Jersey, United States
SectorBiotechnology
Websitelegendbiotech.com
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.28 / -$0.17
-63.35%miss
Revenue / Est. (USD)
305.10M / 306.52M
-0.46%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
255.06M
272.33M
306.38M
305.10M
Cost of goods sold
196.29M
228.45M
224.78M
261.60M
Cost of revenue
196.29M
228.45M
224.78M
261.60M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
80.65M
87.33M
101.19M
90.10M
Operating expense
80.65M
87.33M
102.19M
93.30M
Total operating expenses
276.94M
315.78M
326.98M
354.90M
Operating income
-21.88M
-43.45M
-20.60M
-49.80M
Other non operating income
1.14M
-654.00K
3.29M
-500.00K
EBT including unusual items
-124.80M
-39.07M
-19.60M
-53.10M
EBT excluding unusual items
-124.80M
-39.07M
-20.57M
-53.10M
Income tax expense
582.00K
616.00K
11.22M
1.20M
Effective tax rate
-0.47%
-1.58%
-57.23%
-2.26%
Other operating expenses
-
-
1.00M
3.20M
Net income
-125.38M
-39.69M
-30.82M
-54.30M
Net profit margin
-49.16%
-14.57%
-10.06%
-17.80%
Earnings per share
-0.68
-0.22
-0.16
-0.28
Interest and investment income
10.43M
9.66M
7.95M
7.30M
Interest expense
-4.50M
-4.50M
-7.80M
-4.20M
Net interest expenses
5.93M
5.16M
150.00K
3.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.50M
-41.53M
-17.92M
-47.40M
Gain or loss from assets sale
197.00K
-250.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer